Article info
PDFOvarian Cancer
Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer
- Address correspondence and reprint requests to Hans-Christian Bösmüller, MD, Institute of Pathology, University Hospital of Tübingen, Liebermeisterstraße 8, D-72076 Tübingen, Germany. E-mail: hans.boesmueller{at}med.uni-tuebingen.de.
Citation
Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer
Publication history
- Received October 19, 2015
- Accepted January 3, 2016
- First published May 1, 2016.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.